ID: ALA4075750

Max Phase: Preclinical

Molecular Formula: C11H16N4O

Molecular Weight: 220.28

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1nc(N2CCC2)nc(N2CCC2)c1O

Standard InChI:  InChI=1S/C11H16N4O/c1-8-9(16)10(14-4-2-5-14)13-11(12-8)15-6-3-7-15/h16H,2-7H2,1H3

Standard InChI Key:  LJWAJPFBVHOEHO-UHFFFAOYSA-N

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 220.28Molecular Weight (Monoisotopic): 220.1324AlogP: 0.91#Rotatable Bonds: 2
Polar Surface Area: 52.49Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 10.72CX Basic pKa: 7.65CX LogP: 1.14CX LogD: 0.71
Aromatic Rings: 1Heavy Atoms: 16QED Weighted: 0.80Np Likeness Score: -1.15

References

1. Chevalier A, Khdour OM, Schmierer M, Bandyopadhyay I, Hecht SM..  (2017)  Influence of substituent heteroatoms on the cytoprotective properties of pyrimidinol antioxidants.,  25  (5): [PMID:28189395] [10.1016/j.bmc.2017.01.030]

Source